Gregoire Ramade - Jan 2, 2024 Form 3/A - Amendment Insider Report for Inogen Inc (INGN)

Role: Chief Commercial Officer
Signature: /s/ Mary Wright, as Attorney-in-Fact
Stock symbol: INGN
Transactions as of: Jan 2, 2024
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 12/3/2024, 05:01 PM
Date Of Original Report: Jan 11, 2024
Previous filing: Jan 4, 2023
Next filing: Dec 3, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	INGN	Restricted Stock Unit							Jan 2, 2024	Common Stock	94.7K	$0.00	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F2	Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Remarks:

This Form 3/A is being filed to include a grant of restricted stock units awarded on November 6, 2023 which was inadventently omitted from in the original Form 3 filed on January 11, 2024 due to administrative error.